Financial Survey: International Money Express (IMXI) versus Protagenic Therapeutics (PTIX)

International Money Express (NASDAQ:IMXI) and Protagenic Therapeutics (OTCMKTS:PTIX) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Analyst Recommendations

This is a summary of recent ratings and price targets for International Money Express and Protagenic Therapeutics, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
International Money Express 0 0 5 0 3.00
Protagenic Therapeutics 0 0 0 0 N/A

International Money Express presently has a consensus price target of $15.00, indicating a potential upside of 25.94%. Given International Money Express’ higher possible upside, analysts plainly believe International Money Express is more favorable than Protagenic Therapeutics.

Profitability

This table compares International Money Express and Protagenic Therapeutics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
International Money Express N/A -2.23% -1.11%
Protagenic Therapeutics N/A -633.97% -242.25%

Earnings and Valuation

This table compares International Money Express and Protagenic Therapeutics’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
International Money Express $273.90 million 1.57 -$7.24 million ($0.05) -238.20
Protagenic Therapeutics N/A N/A -$2.56 million N/A N/A

Protagenic Therapeutics has lower revenue, but higher earnings than International Money Express.

Insider and Institutional Ownership

29.3% of International Money Express shares are held by institutional investors. 51.1% of Protagenic Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

International Money Express beats Protagenic Therapeutics on 6 of the 8 factors compared between the two stocks.

About International Money Express

International Money Express, Inc. operates as a money remittance services company in the United States, Latin America, Mexico, Central and South America, and the Caribbean. The company offers remittance services, including a suite of ancillary financial processing solutions and payment services. It provides sending and paying agents and company-owned stores, as well as online and through Internet-enabled mobile devices. International Money Express, Inc. is headquartered in Miami, Florida.

About Protagenic Therapeutics

Protagenic Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder. The company is based in New York, New York.

Receive News & Ratings for International Money Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Money Express and related companies with MarketBeat.com's FREE daily email newsletter.